Quarterly Results

202601 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

More

Earnings

CategoryQ2 FY25-26Q2 FY24-25Change %FY24-25FY23-24Change %
Total Revenue6,123.205,237.0016.9223,241.5019,547.4018.90
Expenses4,141.603,775.609.6916,402.6014,177.3015.70
Other Income109.0068.5059.12269.50307.10-12.24
Operating Profit210.3093.60124.687,108.405,677.2025.21
Depreciation301.90233.6029.24915.80764.1019.85
Interest101.3025.10303.59165.9081.20104.31
Profit Before Tax1,692.601,293.3030.876,026.704,831.9024.73
Tax454.00373.1021.682,049.301,492.6037.30
Net Profit1,292.80910.9041.934,614.803,854.4019.73
CategoryQ2 FY25-26Q1 FY25-26Change %
Total Revenue6,123.206,573.70-6.85
Expenses4,141.604,485.20-7.66
Other Income109.00154.90-29.63
Operating Profit210.30239.60-12.23
Depreciation301.90238.1026.80
Interest101.3084.7019.60
Profit Before Tax1,692.601,955.00-13.42
Tax454.00434.004.61
Net Profit1,292.801,466.80-11.86

Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Data Not Found

Corporate Information

Company News

Stocks to Watch today, Nov 26: Airtel, Nelco, Welspun Corp, Asian Paints

Stocks to Watch Today, November 26, 2025: From Bharti Airtel to Nelco; here is a list of stocks that will be in focus today

Updated On: 26 Nov 2025 | 7:36 AM IST

Zydus Lifesciences marks China entry with approval for antidepressant drug

Indian drug cos Chinese pipelines start getting regulator nod; Glenmark got nod for nasal spray this week

Updated On: 11 Nov 2025 | 2:50 PM IST

Zydus Life Q2: Solid beat on bottom line, analysts mixed on growth outlook

Zydus Life Q2 results review: Foreign brokerage Nomura said Zydus Life delivered results above estimates, led by a stronger-than-expected performance in India.

Updated On: 07 Nov 2025 | 9:28 AM IST

Zydus PAT up 38% on strong India, US growth; board okays ₹5K cr fundraise

Zydus Lifesciences reported a 17% YoY rise in revenue to Rs 6,123 crore and a 38% jump in profit to Rs 1,258.6 crore in Q2 FY26, driven by India and US formulations performance

Updated On: 06 Nov 2025 | 6:18 PM IST

Stocks to Watch today, Nov 4: Bharti Airtel, Titan, Hero MotoCorp, Cipla

Stocks to Watch today, November 4, 2025: From Bharti Airtel, Hero MotoCorp, Titan Company, and Power Grid, here is a list of stocks that will be in focus today

Updated On: 04 Nov 2025 | 8:05 AM IST

Stocks to Watch today: Coal India, L&T, Wipro, Bharti Airtel, Ola Electric

Stocks to Watch Today, October 30, 2025: Wipro, L&T, Coal India, United Breweries, Ola Electric, ITC, Swiggy, Mankind Pharma, and Dr Reddy's Labs are among the top stocks to watch today

Updated On: 30 Oct 2025 | 7:08 AM IST

Stocks to Watch today, Oct 7: LTIMindtree, Bank of India, HCL Tech, OIL

Stocks to Watch today, October 7, 2025: From Bank of India, HCL Tech to Eternal, here is a list of stocks that will be in focus

Updated On: 07 Oct 2025 | 8:12 AM IST

Tariff uncertainties may spur rise in third-party pharma manufacturing

Analysts say Indian drugmakers may lean on CDMOs, US plants and diversification to safeguard high-value products as Trump's 100% tariff threat looms over patented drugs

Updated On: 28 Sep 2025 | 1:48 PM IST

Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded

Among individual counters, Sun Pharma slumped 4.87 per cent to a fresh 52-week low of ₹1,548, while Gland Pharma tumbled 4.70 per cent to ₹1,880. Biocon declined 3.68 per cent to ₹342.85.

Updated On: 26 Sep 2025 | 9:13 AM IST

Stocks to watch today, Sep 8: SpiceJet, TaMo, M&M, Vedanta, BHEL, HFCL

Stocks to watch today, September 8, 2025 | Aurobindo Pharma: USFDA issued 8 procedural observations after inspecting Telangana Unit-XII.

Updated On: 08 Sep 2025 | 7:40 AM IST
More